ICON_Jan2021_CellandGeneTherapy - 12
The Critical Role of a CRO in Cell and Gene Trials
critically important. " The thing that I find the most
order the courier. We order the shipper and collection
challenging about monitoring CGT studies is that
kits that get packed out and overnighted via air
there are multiple moving pieces, as many as 10 to
to the manufacturing facility, which needs to start
15, " says Sarah Allenson, Senior Clinical Research
the manufacturing process as soon as they receive
Associate with ICON. " Picture a clock with gears and
it. And if a patient becomes ill or cannot make the
how they work together. If you move this gear it
appointment, which is often the case in CGT, we're
affects another gear and that changes another gear.
rearranging everything from end to end. "
And if something gets stuck in the gear, it can wreak
With so much riding on the timely pickup and
havoc all down the line. That's pretty much what we
delivery of the cells and proper handling, it is not
live and breathe every day in a CGT trial. It's all about
surprising that the COVID-19 pandemic has further
the details. "
challenged sponsors and their CRO partners to
Allenson notes, " The cohorts of CGT trials are
typically not large, perhaps only a dozen or a couple
dozen participants, and can be spread among
ensure the collection, packing, and delivery of cells
continues to go off without a hitch.
" This became very evident during the Covid
multiple trial sites. That means arranging apheresis
pandemic. We have to pay close attention to staffing
for the participants in multiple locations, all on the
changes and reassignments to ensure anyone
day before the cleanroom is available. We schedule
handing the IP is properly trained. Training and
the patient for the apheresis. We collect the cells. We
reminders have become a standard practice, " says
12 |
ClinicalOMICs.com
http://www.ClinicalOMICs.com
ICON_Jan2021_CellandGeneTherapy
Table of Contents for the Digital Edition of ICON_Jan2021_CellandGeneTherapy
Contents
ICON_Jan2021_CellandGeneTherapy - 1
ICON_Jan2021_CellandGeneTherapy - 2
ICON_Jan2021_CellandGeneTherapy - Contents
ICON_Jan2021_CellandGeneTherapy - 4
ICON_Jan2021_CellandGeneTherapy - 5
ICON_Jan2021_CellandGeneTherapy - 6
ICON_Jan2021_CellandGeneTherapy - 7
ICON_Jan2021_CellandGeneTherapy - 8
ICON_Jan2021_CellandGeneTherapy - 9
ICON_Jan2021_CellandGeneTherapy - 10
ICON_Jan2021_CellandGeneTherapy - 11
ICON_Jan2021_CellandGeneTherapy - 12
ICON_Jan2021_CellandGeneTherapy - 13
ICON_Jan2021_CellandGeneTherapy - 14
ICON_Jan2021_CellandGeneTherapy - 15
ICON_Jan2021_CellandGeneTherapy - 16
ICON_Jan2021_CellandGeneTherapy - 17
ICON_Jan2021_CellandGeneTherapy - 18
ICON_Jan2021_CellandGeneTherapy - 19
ICON_Jan2021_CellandGeneTherapy - 20
ICON_Jan2021_CellandGeneTherapy - 21
ICON_Jan2021_CellandGeneTherapy - 22
ICON_Jan2021_CellandGeneTherapy - 23
ICON_Jan2021_CellandGeneTherapy - 24
ICON_Jan2021_CellandGeneTherapy - 25
ICON_Jan2021_CellandGeneTherapy - 26
ICON_Jan2021_CellandGeneTherapy - 27
ICON_Jan2021_CellandGeneTherapy - 28
ICON_Jan2021_CellandGeneTherapy - 29
ICON_Jan2021_CellandGeneTherapy - 30
https://www.nxtbookmedia.com